BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 11168575)

  • 1. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
    Hanifin JM; Thurston M; Omoto M; Cherill R; Tofte SJ; Graeber M
    Exp Dermatol; 2001 Feb; 10(1):11-8. PubMed ID: 11168575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis.
    Baek JH; Park CW; Choi KM; Yang YS; Lee SY; Koh JS; Chung BY; Kim HO; Park GH
    Int J Dermatol; 2015 Dec; 54(12):1382-9. PubMed ID: 25556325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA.
    Bożek A; Reich A
    Dermatology; 2017; 233(1):16-22. PubMed ID: 28494438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
    Schmitt J; Langan S; Deckert S; Svensson A; von Kobyletzki L; Thomas K; Spuls P;
    J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot comparison study of four clinician-rated atopic dermatitis severity scales.
    Zhao CY; Tran AQ; Lazo-Dizon JP; Kim J; Daniel BS; Venugopal SS; Rhodes LM; Law MG; Murrell DF
    Br J Dermatol; 2015 Aug; 173(2):488-97. PubMed ID: 25891151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients.
    Zhao CY; Hao EY; Oh DD; Daniel BS; Martin LK; Su JC; Rodrigues M; Murrell DF
    Br J Dermatol; 2017 Apr; 176(4):985-992. PubMed ID: 28012183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
    Barbier N; Paul C; Luger T; Allen R; De Prost Y; Papp K; Eichenfield LF; Cherill R; Hanifin J
    Br J Dermatol; 2004 Jan; 150(1):96-102. PubMed ID: 14746622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos.
    Croce EA; Rathouz PJ; Lopes FCPS; Leszczynska M; Diaz LZ; Levy ML; Ruth JS; Varshney P; Rew L; Matsui EC
    Pediatr Dermatol; 2022 Jul; 39(4):547-552. PubMed ID: 35522088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
    Chopra R; Vakharia PP; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
    Br J Dermatol; 2017 Nov; 177(5):1316-1321. PubMed ID: 28485036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Br J Dermatol; 2021 May; 184(5):888-895. PubMed ID: 32959390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic Dermatitis in Children in the General Population: Baseline Characteristics, Medication Use, and Severity Measures in the Rotterdam Eczema Study.
    van Halewijn KF; van der Most F; Bohnen AM; Pasmans SGMA; Bindels PJE; Elshout G
    Dermatitis; 2024; 35(1):61-69. PubMed ID: 37015063
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children.
    Suh TP; Ramachandran D; Patel V; Jackson KL; Rangel SM; Fishbein AB; Paller AS
    J Am Acad Dermatol; 2020 May; 82(5):1187-1194. PubMed ID: 31972257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severity.
    van Velsen SG; Knol MJ; Haeck IM; Bruijnzeel-Koomen CA; Pasmans SG
    Pediatr Dermatol; 2010; 27(5):470-5. PubMed ID: 20796235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study.
    Housman TS; Patel MJ; Camacho F; Feldman SR; Fleischer AB; Balkrishnan R
    Br J Dermatol; 2002 Dec; 147(6):1192-8. PubMed ID: 12452870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score.
    Charman CR; Venn AJ; Williams HC
    Br J Dermatol; 2002 Jun; 146(6):1057-60. PubMed ID: 12072077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.
    Simpson EL; Bissonnette R; Paller AS; King B; Silverberg JI; Reich K; Thyssen JP; Doll H; Sun L; DeLozier AM; Nunes FP; Eichenfield LF
    Br J Dermatol; 2022 Oct; 187(4):531-538. PubMed ID: 35442530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild to moderate atopic dermatitis severity can be reliably assessed using smartphone-photographs taken by the patient at home: A validation study.
    Ali Z; Chiriac A; Bjerre-Christensen T; Isberg AP; Dahiya P; Manole I; Dutei AM; Deaconescu I; Serban A; Suru A; Agner T; Kamstrup MR; Togsverd-Bo K; Zibert JR; Thomsen SF; Andersen AD
    Skin Res Technol; 2022 Mar; 28(2):336-341. PubMed ID: 35020960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.
    Leshem YA; Hajar T; Hanifin JM; Simpson EL
    Br J Dermatol; 2015; 172(5):1353-7. PubMed ID: 25580670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.